fda warning on semaglutide The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of data showed. Added Semaglutide shortage ends as FDA

A sensitized high-throughput screen was used to identify 5-fluoropyrimidine-based GLP-1R agonists that were optimized to promote endogenous GLP-1R signaling with nanomolar potency

US Food and Drug Administration (FDA) guidelines list furosemide as a suitable victim drug to test potential DDIs for OAT1 and/or OAT3 and rosuvastatin as a suitable victim drug to test potential DDIs for BCRP, OAT1 and/or OAT3 and OATP1B1 [33]

Use Savings Programs : Programs like the Wegovy Savings Card or NovoCare Pharmacy can reduce costs to as low as $25$499/month for eligible users

Some people find they tolerate alcohol differently after starting a GLP-1 medication

Compounded semaglutide was the first wave

Cell 85 , 26732687.e2678 (2025)